AstraZeneca said it has resumed Phase 3 clinical trials for its new coronavirus vaccine candidate in the United Kingdom after regulators determined it was safe to do so, in today's bite-sized hospital and health industry news from the Delaware, Virginia, and Washington.
Earlier this month, a new JAMA Network Open survey made the news for its startling findings: Nearly 50% of U.S. adults report at least some signs of depression—a serious behavioral health issue that is rapidly becoming a large-scale crisis. To help, Advisory Board's Clare Wirth shares four steps health systems can take now to address urgent needs in their workforce and patient population.
A top HHS official on Sunday accused CDC career scientists of "sedition," saying they "haven't gotten out of their sweatpants except for meetings at coffee shops" to plan "how they're going to attack Donald Trump next." Meanwhile, a House subcommittee on Monday said it would investigate whether HHS political appointees interfered with CDC's weekly reports on the new coronavirus.
While many Covid-19 patients recover relatively quickly, plenty of others are so-called "long-haulers" who face ongoing complications as a result of the disease. To help, hospitals nationwide have started establishing Covid-19 recovery programs to give patients access to a support system of specialists.
President Trump on Sunday signed an order aiming to tie Medicare prescription drug payments to the lowest price offered in other developed nations—a "shocking move," according to STAT News, that prompted widely varying predictions about what will happen next. Advisory Board's Manasi Kapoor and Pam Divack break down what you need to know.
Restaurants, offices, and other locations open for business amid the coronavirus pandemic are increasingly relying on temperature checks to screen people for infection—but federal officials and public health experts say the practice is largely performative. Here's what they recommend instead.
